Andrea Pellagatti

Oxford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 93 publications

MDMX acts as a pervasive preleukemic-to-acute myeloid leukemia transition mechanism.

MDMX acts as a pervasive preleukemic-to-acute myeloid leukemia transition mechanism.

Journal: Cancer cell

Published: August 27, 2026

Chromatin rewiring of β-globin and MYC enhancers by TGF-β1 drives defective erythropoiesis.

Chromatin rewiring of β-globin and MYC enhancers by TGF-β1 drives defective erythropoiesis.

Journal: Nature communications

Published: July 30, 2025

Identification of new candidate drugs in myelodysplastic syndromes with splicing factor mutations by transcriptional profiling and connectivity map analysis.

Identification of new candidate drugs in myelodysplastic syndromes with splicing factor mutations by transcriptional profiling and connectivity map analysis.

Journal: British journal of haematology

Published: November 26, 2024

Splicing of erythroid transcription factor is associated with therapeutic response in myelodysplastic syndromes.

Splicing of erythroid transcription factor is associated with therapeutic response in myelodysplastic syndromes.

Journal: The Journal of clinical investigation

Published: November 18, 2024

Hyperactivation of NF-κB signaling in splicing factor mutant myelodysplastic syndromes and therapeutic approaches.

Hyperactivation of NF-κB signaling in splicing factor mutant myelodysplastic syndromes and therapeutic approaches.

Journal: Advances in biological regulation

Published: September 08, 2024

Identification of novel myelodysplastic syndromes prognostic subgroups by integration of inflammation, cell-type composition, and immune signatures in the bone marrow.

Identification of novel myelodysplastic syndromes prognostic subgroups by integration of inflammation, cell-type composition, and immune signatures in the bone marrow.

Journal: eLife

Published: September 05, 2024

Molecular taxonomy of myelodysplastic syndromes and its clinical implications.

Molecular taxonomy of myelodysplastic syndromes and its clinical implications.

Journal: Blood

Published: January 03, 2024

Molecular and clinical presentation of UBA1-mutated myelodysplastic syndromes.

Molecular and clinical presentation of UBA1-mutated myelodysplastic syndromes.

Journal: Blood

Published: December 22, 2023

Recent advances in the application of induced pluripotent stem cell technology to the study of myeloid malignancies.

Recent advances in the application of induced pluripotent stem cell technology to the study of myeloid malignancies.

Journal: Advances in biological regulation

Published: September 22, 2023

Ribosomal protein control of hematopoietic stem cell transformation through direct, non-canonical regulation of metabolism.

Ribosomal protein control of hematopoietic stem cell transformation through direct, non-canonical regulation of metabolism.

Journal: bioRxiv : the preprint server for biology

Published: July 03, 2023

Ribosomal protein control of hematopoietic stem cell transformation through regulation of metabolism.

Ribosomal protein control of hematopoietic stem cell transformation through regulation of metabolism.

Journal: Cell reports

Published: June 02, 2023

A miRNA screening identifies miR-192-5p as associated with response to azacitidine and lenalidomide therapy in myelodysplastic syndromes.

A miRNA screening identifies miR-192-5p as associated with response to azacitidine and lenalidomide therapy in myelodysplastic syndromes.

Journal: Clinical epigenetics

Published: October 05, 2022

Showing 1-12 of 93

Last Updated: 09/26/2026